TCBPW Total Current Assets vs Total Current Liabilities Analysis

TCBPW Stock

USD 0.02 0 24.67%

TC BioPharm financial indicator trend analysis is much more than just breaking down TC BioPharm plc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether TC BioPharm plc is a good investment. Please check the relationship between TC BioPharm Total Current Assets and its Total Current Liabilities accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TC BioPharm plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Total Current Assets vs Total Current Liabilities

Total Current Assets vs Total Current Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of TC BioPharm plc Total Current Assets account and Total Current Liabilities. At this time, the significance of the direction appears to have almost no relationship.

The correlation between TC BioPharm's Total Current Assets and Total Current Liabilities is 0.15. Overlapping area represents the amount of variation of Total Current Assets that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of TC BioPharm plc, assuming nothing else is changed. The correlation between historical values of TC BioPharm's Total Current Assets and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Assets of TC BioPharm plc are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Total Current Assets i.e., TC BioPharm's Total Current Assets and Total Current Liabilities go up and down completely randomly.

Correlation Coefficient

0.15

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.

Total Current Liabilities

Total Current Liabilities is an item on TC BioPharm balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of TC BioPharm plc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most indicators from TC BioPharm's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into TC BioPharm plc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TC BioPharm plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Tax Provision is likely to drop to about (1.1 M) in 2024. Selling General Administrative is likely to drop to about 5.1 M in 2024

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	812.0K	762.5K	630.1K	638.0K
Interest Income	33.0	2.2K	2.0K	1.9K

Depreciation And Amortization Interest Income

TC BioPharm fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Lease Obligations	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Capital Stock
Total Assets		-0.44	-0.34	-0.35	0.47	0.29	0.05	-0.49	0.23	-0.38	0.29	0.28	-0.46	0.29	0.6	0.33	0.2	0.14	-0.6	0.46	0.02	-0.26	0.41	0.01	0.62	0.18
Short Long Term Debt Total	-0.44		0.68	0.84	-0.95	-0.13	0.28	0.96	-0.17	0.3	-0.09	-0.12	0.76	-0.09	-0.19	-0.5	-0.08	0.09	0.17	-0.45	0.3	0.94	-0.83	0.05	-0.22	-0.26
Other Current Liab	-0.34	0.68		0.9	-0.54	-0.67	-0.17	0.45	-0.65	0.54	0.61	-0.66	0.94	0.61	-0.68	-0.61	-0.67	-0.53	0.66	-0.71	0.64	0.54	-0.33	-0.35	0.3	-0.69
Total Current Liabilities	-0.35	0.84	0.9		-0.67	-0.57	-0.18	0.67	-0.63	0.57	0.38	-0.58	0.96	0.38	-0.57	-0.4	-0.57	-0.4	0.56	-0.47	0.61	0.73	-0.45	-0.45	0.15	-0.69
Total Stockholder Equity	0.47	-0.95	-0.54	-0.67		-0.13	-0.54	-0.97	-0.1	-0.03	0.29	-0.13	-0.57	0.29	0.02	0.64	-0.17	-0.34	0.0	0.54	-0.02	-0.96	0.96	-0.27	0.44	-0.03
Property Plant And Equipment Net	0.29	-0.13	-0.67	-0.57	-0.13		0.83	0.11	0.98	-0.88	-0.76	1.0	-0.73	-0.76	0.91	-0.06	0.99	0.98	-0.91	0.18	-0.83	0.13	-0.38	0.71	-0.54	0.96
Current Deferred Revenue	0.05	0.28	-0.17	-0.18	-0.54	0.83		0.43	0.85	-0.78	-0.57	0.84	-0.31	-0.57	0.68	-0.58	0.84	0.9	-0.69	-0.35	-0.67	0.49	-0.74	0.76	-0.53	0.81
Net Debt	-0.49	0.96	0.45	0.67	-0.97	0.11	0.43		0.06	0.13	-0.38	0.11	0.56	-0.38	-0.01	-0.44	0.16	0.32	0.0	-0.35	0.05	0.94	-0.91	0.21	-0.47	-0.02
Retained Earnings	0.23	-0.17	-0.65	-0.63	-0.1	0.98	0.85	0.06		-0.88	-0.73	0.99	-0.74	-0.73	0.87	-0.14	0.99	0.95	-0.88	0.09	-0.84	0.06	-0.37	0.79	-0.54	0.99
Accounts Payable	-0.38	0.3	0.54	0.57	-0.03	-0.88	-0.78	0.13	-0.88		0.49	-0.88	0.72	0.49	-0.76	0.24	-0.83	-0.82	0.76	0.05	0.88	0.0	0.22	-0.49	0.39	-0.9
Cash	0.29	-0.09	0.61	0.38	0.29	-0.76	-0.57	-0.38	-0.73	0.49		-0.75	0.48	1.0	-0.54	-0.11	-0.81	-0.81	0.54	-0.24	0.75	-0.2	0.47	-0.54	0.89	-0.74
Non Current Assets Total	0.28	-0.12	-0.66	-0.58	-0.13	1.0	0.84	0.11	0.99	-0.88	-0.75		-0.73	-0.75	0.91	-0.08	0.99	0.97	-0.91	0.16	-0.83	0.13	-0.39	0.73	-0.53	0.97
Non Currrent Assets Other	-0.46	0.76	0.94	0.96	-0.57	-0.73	-0.31	0.56	-0.74	0.72	0.48	-0.73		0.48	-0.72	-0.39	-0.71	-0.57	0.71	-0.51	0.72	0.58	-0.33	-0.43	0.22	-0.79
Cash And Short Term Investments	0.29	-0.09	0.61	0.38	0.29	-0.76	-0.57	-0.38	-0.73	0.49	1.0	-0.75	0.48		-0.54	-0.11	-0.81	-0.81	0.54	-0.24	0.75	-0.2	0.47	-0.54	0.89	-0.74
Net Receivables	0.6	-0.19	-0.68	-0.57	0.02	0.91	0.68	-0.01	0.87	-0.76	-0.54	0.91	-0.72	-0.54		0.15	0.89	0.85	-1.0	0.41	-0.58	0.06	-0.2	0.64	-0.18	0.81
Common Stock Shares Outstanding	0.33	-0.5	-0.61	-0.4	0.64	-0.06	-0.58	-0.44	-0.14	0.24	-0.11	-0.08	-0.39	-0.11	0.15		-0.06	-0.18	-0.12	0.96	0.13	-0.54	0.66	-0.29	0.21	-0.13
Non Current Liabilities Total	0.2	-0.08	-0.67	-0.57	-0.17	0.99	0.84	0.16	0.99	-0.83	-0.81	0.99	-0.71	-0.81	0.89	-0.06		0.98	-0.89	0.18	-0.82	0.14	-0.43	0.77	-0.59	0.96
Capital Lease Obligations	0.14	0.09	-0.53	-0.4	-0.34	0.98	0.9	0.32	0.95	-0.82	-0.81	0.97	-0.57	-0.81	0.85	-0.18	0.98		-0.85	0.06	-0.8	0.33	-0.57	0.71	-0.63	0.92
Inventory	-0.6	0.17	0.66	0.56	0.0	-0.91	-0.69	0.0	-0.88	0.76	0.54	-0.91	0.71	0.54	-1.0	-0.12	-0.89	-0.85		-0.38	0.58	-0.06	0.21	-0.66	0.18	-0.82
Other Current Assets	0.46	-0.45	-0.71	-0.47	0.54	0.18	-0.35	-0.35	0.09	0.05	-0.24	0.16	-0.51	-0.24	0.41	0.96	0.18	0.06	-0.38		0.0	-0.43	0.52	-0.09	0.16	0.07
Other Stockholder Equity	0.02	0.3	0.64	0.61	-0.02	-0.83	-0.67	0.05	-0.84	0.88	0.75	-0.83	0.72	0.75	-0.58	0.13	-0.82	-0.8	0.58	0.0		0.06	0.24	-0.44	0.73	-0.9
Total Liab	-0.26	0.94	0.54	0.73	-0.96	0.13	0.49	0.94	0.06	0.0	-0.2	0.13	0.58	-0.2	0.06	-0.54	0.14	0.33	-0.06	-0.43	0.06		-0.9	0.11	-0.3	-0.03
Net Invested Capital	0.41	-0.83	-0.33	-0.45	0.96	-0.38	-0.74	-0.91	-0.37	0.22	0.47	-0.39	-0.33	0.47	-0.2	0.66	-0.43	-0.57	0.21	0.52	0.24	-0.9		-0.47	0.58	-0.31
Property Plant And Equipment Gross	0.01	0.05	-0.35	-0.45	-0.27	0.71	0.76	0.21	0.79	-0.49	-0.54	0.73	-0.43	-0.54	0.64	-0.29	0.77	0.71	-0.66	-0.09	-0.44	0.11	-0.47		-0.38	0.75
Total Current Assets	0.62	-0.22	0.3	0.15	0.44	-0.54	-0.53	-0.47	-0.54	0.39	0.89	-0.53	0.22	0.89	-0.18	0.21	-0.59	-0.63	0.18	0.16	0.73	-0.3	0.58	-0.38		-0.58
Capital Stock	0.18	-0.26	-0.69	-0.69	-0.03	0.96	0.81	-0.02	0.99	-0.9	-0.74	0.97	-0.79	-0.74	0.81	-0.13	0.96	0.92	-0.82	0.07	-0.9	-0.03	-0.31	0.75	-0.58

Click cells to compare fundamentals

TC BioPharm Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for TCBPW Stock Analysis

When running TC BioPharm's price analysis, check to measure TC BioPharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TC BioPharm is operating at the current time. Most of TC BioPharm's value examination focuses on studying past and present price action to predict the probability of TC BioPharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TC BioPharm's price. Additionally, you may evaluate how the addition of TC BioPharm to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

TCBPW Total Current Assets vs Total Current Liabilities Analysis

Total Current Assets vs Total Current Liabilities

Total Current Assets vs Total Current Liabilities Correlation Analysis

Correlation Coefficient

Total Current Assets

Total Current Liabilities

TC BioPharm fundamental ratios Correlations

TC BioPharm Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for TCBPW Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Non Current Liabilities Total	+ 0.99	Property Plant And Equipment Net
Non Current Assets Total	+ 0.99	Retained Earnings
Non Current Liabilities Total	+ 0.99	Retained Earnings
Capital Stock	+ 0.99	Retained Earnings

Inventory	- 1.0	Net Receivables
Net Debt	- 0.97	Total Stockholder Equity
Total Liab	- 0.96	Total Stockholder Equity
Total Stockholder Equity	- 0.95	Short Long Term Debt Total
Inventory	- 0.91	Non Current Assets Total
Net Invested Capital	- 0.91	Net Debt